PTEN and triple-negative breast carcinoma: In addition, LNPs conjugated with PD-L1-binding peptides selectively delivered mRNA encoding phosphatase and tensin homolog (PTEN) to triple-negative breast cancer (TNBC) cells, which effectively induced anticancer immune response and reduced tumor growth in orthotopic and metastatic models [22].